Crossmark

Novel technologies for improving the safety and efficacy of CAR-T cell therapy

Published Online: 2022-10-29

Published Print: 2023-05

Authors

Ohta, Keisuke

Sakoda, Yukimi

Tamada, Koji
License Information

Text and Data Mining valid from 2022-10-29

Version of Record valid from 2022-10-29
More Information

Article History

Received: 27 August 2022

Revised: 13 October 2022

Accepted: 19 October 2022

First Online: 29 October 2022

Declarations

:

: KT and YS is shareholder at Noile-Immune Biotech Inc., and receive remuneration from Noile-Immune Biotech Inc.

Document is current